Ascorbate Preferentially Stimulates Gallium-67 Uptake in Glioblastoma Cells

Area of Science:

• Biomedical imaging
• Cancer therapy
• Cellular metabolism

Background:

• Gallium mimics iron and enters cells via transferrin receptors.
• Gallium isotopes (Ga-67, Ga-68) are used for tumor and inflammation imaging.
• Pharmacological ascorbate is an experimental glioblastoma therapy targeting iron metabolism.

Purpose of the Study:

• To investigate if pharmacological ascorbate affects gallium uptake in glioblastoma cells.
• To determine if this effect is specific to cancer cells.

Main Methods:

• Patient-derived glioblastoma cells and normal human astrocytes were used.
• Cells were co-incubated with Ga-67 in the presence or absence of pharmacological ascorbate.
• Gallium uptake was measured.

Main Results:

• Glioblastoma cells exhibited higher basal gallium uptake than normal astrocytes.
• Pharmacological ascorbate significantly increased gallium uptake in glioblastoma cells.
• Ascorbate did not alter gallium uptake in normal astrocytes.
• The effect appears linked to increased transferrin receptor expression and iron metabolism.

Conclusions:

• Pharmacological ascorbate enhances gallium uptake in glioblastoma cells, potentially via transferrin receptor modulation.
• This interaction with iron metabolism warrants further investigation for clinical applications in gallium-based imaging.